Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences
  • Healthcare
Life Sciences

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences
Healthcare

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

Launch Excellence, the U.S. Edition: The Rewrite of the Business of Launch – Optimize

"Aligning legislative requirements, payer expectations regarding pricing and evidence, and meeting patients’ needs is now crucial for successful launches.

Learn more
MAIN/Contact Us
Contact Us/
Insight Brief
Quality Management Considerations for Emerging Companies in the Pharmaceutical Industry
May 08, 2024
  • Locations
  • United States
  • Quality Management Considerations for Emerging Companies in the Pharmaceutical Industry
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

For many small to midsize biopharma companies in today's drug market, adherence to FDA regulations when bringing a new biologic or synthetic drug to market is not optional, it is required. A company can risk wasting valuable time, money, and resources if certain aspects of Quality Management are not built into the early phases of the product development and launch processes and if the organization does not follow current Good Manufacturing Practices (cGMPs). This insight brief offers thoughts on what companies need to know.

Related solutions

Safety & Regulatory Compliance

Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.

Quality Compliance

From manufacturing oversight to regulatory requirements, manage quality across your organization with a single enterprise software solution.

Contact Us